Northern Trust Corp Alvotech Transaction History
Northern Trust Corp
- $586 Billion
- Q2 2024
A detailed history of Northern Trust Corp transactions in Alvotech stock. As of the latest transaction made, Northern Trust Corp holds 110,114 shares of ALVO stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,114
Previous 121,257
9.19%
Holding current value
$1.4 Million
Previous $1.48 Million
9.66%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALVO
# of Institutions
34Shares Held
15MCall Options Held
100KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA3.16MShares$40.3 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$34.5 Million47.01% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca2.53MShares$32.3 Million0.61% of portfolio
-
Littlejohn & CO LLC1.32MShares$16.8 Million6.78% of portfolio
-
Legal & General Group PLC London, X01MShares$12.8 Million0.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.17B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...